Interferon-β Induces Hepatocyte Growth Factor in Monocytes of Multiple Sclerosis Patients

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Molnarfi, Nicolas ^a,b   Benkhoucha, Mahdia ^a,b   Bjarnadóttir, Kristbjörg ^a,b   Juillard, Catherine ^a   Lalive, Patrice H ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CD14 ANTIGEN; CORTICOSTEROID; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MECHANISM; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LIVER CELL; LONG TERM CARE; MALE; MONOCYTE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERFERON-BETA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWITZERLAND;

EID: 84869140690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049882     Document Type: Article

References (38)

1. Sospedra M, Martin R, (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23: 683-747.
2. Hemmer B, Hartung HP, (2007) Toward the development of rational therapies in multiple sclerosis: what is on the horizon? Ann Neurol 62: 314-326.
3. Benkhoucha M, Santiago-Raber ML, Schneiter G, Chofflon M, Funakoshi H, et al. (2010) Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 107: 6424-6429.
4. Bai L, Lennon DP, Caplan AI, DeChant A, Hecker J, et al. (2012) Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15: 862-879.
5. Ebens A, Brose K, Leonardo ED, Hanson MG Jr, Bladt F, et al. (1996) Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17: 1157-1172.
6. Lalive PH, Paglinawan R, Biollaz G, Kappos EA, Leone DP, et al. (2005) TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. Eur J Immunol 35: 727-737.
7. Kitamura K, Iwanami A, Nakamura M, Yamane J, Watanabe K, et al. (2007) Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J Neurosci Res 85: 2332-2342.
8. Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, et al. (2005) A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 175: 4745-4753.
9. Rutella S, Bonanno G, Procoli A, Mariotti A, de Ritis DG, et al. (2006) Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 108: 218-227.
10. Muller AM, Jun E, Conlon H, Sadiq SA (2012) Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis. J Neuroimmunol.
11. Paty DW, Li DK, (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43: 662-667.
12. Mitsdoerffer M, Kuchroo V, (2009) New pieces in the puzzle: how does interferon-beta really work in multiple sclerosis? Ann Neurol 65: 487-488.
13. Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, et al. (2008) Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System. Immunity.
14. Lalive PH, Kantengwa S, Benkhoucha M, Juillard C, Chofflon M, (2008) Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients. J Neuroimmunol 197: 147-151.
15. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
16. Chiang J, Gloff CA, Yoshizawa CN, Williams GJ, (1993) Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin. Pharm Res 10: 567-572.
17. Khan OA, Xia Q, Bever CT Jr, Johnson KP, Panitch HS, et al. (1996) Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology 46: 1639-1643.
18. Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, et al. (2002) Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology 59: 990-997.
19. Burger D, Molnarfi N, Weber MS, Brandt KJ, Benkhoucha M, et al. (2009) Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci U S A 106: 4355-4359.
20. Fingerle-Rowson G, Angstwurm M, Andreesen R, Ziegler-Heitbrock HW, (1998) Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy. Clin Exp Immunol 112: 501-506.
21. Skibinski G, Skibinska A, James K, (2001) The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunology 102: 506-514.
22. Maina F, Klein R, (1999) Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 2: 213-217.
23. Ohya W, Funakoshi H, Kurosawa T, Nakamura T, (2007) Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat. Brain Res 1147: 51-65.
24. Yan H, Rivkees SA, (2002) Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res 69: 597-606.
25. Di Renzo MF, Bertolotto A, Olivero M, Putzolu P, Crepaldi T, et al. (1993) Selective expression of the Met/HGF receptor in human central nervous system microglia. Oncogene 8: 219-222.
26. Jung W, Castren E, Odenthal M, Vande Woude GF, Ishii T, et al. (1994) Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 126: 485-494.
27. Honda S, Kagoshima M, Wanaka A, Tohyama M, Matsumoto K, et al. (1995) Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res 32: 197-210.
28. Yamagata T, Muroya K, Mukasa T, Igarashi H, Momoi M, et al. (1995) Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. Biochem Biophys Res Commun 210: 231-237.
29. Hamanoue M, Takemoto N, Matsumoto K, Nakamura T, Nakajima K, et al. (1996) Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 43: 554-564.
30. Oppenheim RW, Yin QW, Prevette D, Yan Q, (1992) Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 360: 755-757.
31. Sendtner M, Schmalbruch H, Stockli KA, Carroll P, Kreutzberg GW, et al. (1992) Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358: 502-504.
32. Tsuboi Y, Kakimoto K, Akatsu H, Daikuhara Y, Yamada T, (2002) Hepatocyte growth factor in cerebrospinal fluid in neurologic disease. Acta Neurol Scand 106: 99-103.
33. Kadoyama K, Funakoshi H, Ohya W, Nakamura T, (2007) Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci Res 59: 446-456.
34. Kitamura K, Fujiyoshi K, Yamane J, Toyota F, Hikishima K, et al. (2011) Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. PLoS One 6: e27706.
35. Maier K, Kuhnert AV, Taheri N, Sattler MB, Storch MK, et al. (2006) Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study. Am J Pathol 169: 1353-1364.
36. Sattler MB, Demmer I, Williams SK, Maier K, Merkler D, et al. (2006) Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions. Exp Neurol 201: 172-181.
37. Biernacki K, Antel JP, Blain M, Narayanan S, Arnold DL, et al. (2005) Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis. Arch Neurol 62: 563-568.
38. Galimi F, Cottone E, Vigna E, Arena N, Boccaccio C, et al. (2001) Hepatocyte growth factor is a regulator of monocyte-macrophage function. J Immunol 166: 1241-1247.